Bmpr2 mutations have been demonstrated to sufficiently cause metabolic dysfunction, which is involved in the development of PAH.51 Abnormal BMPR2 function regulates the expression of various metabolism-related genes through alterations in downstream signaling pathways. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.